SK9302002A3 - Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3- benzazocines and the use thereof as medicaments - Google Patents
Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3- benzazocines and the use thereof as medicaments Download PDFInfo
- Publication number
- SK9302002A3 SK9302002A3 SK930-2002A SK9302002A SK9302002A3 SK 9302002 A3 SK9302002 A3 SK 9302002A3 SK 9302002 A SK9302002 A SK 9302002A SK 9302002 A3 SK9302002 A3 SK 9302002A3
- Authority
- SK
- Slovakia
- Prior art keywords
- methyl
- methane
- hexahydro
- compounds
- benzazocine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/26—Benzomorphans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/06—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Reproductive Health (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19957156A DE19957156A1 (de) | 1999-11-27 | 1999-11-27 | Substituierte 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocine und ihre Verwendung als Arzneimittel |
PCT/EP2000/011585 WO2001051471A1 (de) | 1999-11-27 | 2000-11-21 | Substituierte 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine und ihre verwendung als arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
SK9302002A3 true SK9302002A3 (en) | 2002-11-06 |
Family
ID=7930562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK930-2002A SK9302002A3 (en) | 1999-11-27 | 2000-11-21 | Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3- benzazocines and the use thereof as medicaments |
Country Status (33)
Country | Link |
---|---|
EP (1) | EP1235809B1 (xx) |
JP (1) | JP2003519687A (xx) |
KR (1) | KR20020058042A (xx) |
CN (1) | CN1177825C (xx) |
AR (1) | AR026586A1 (xx) |
AT (1) | ATE254108T1 (xx) |
AU (1) | AU5789701A (xx) |
BG (1) | BG106682A (xx) |
BR (1) | BR0015786A (xx) |
CA (1) | CA2383114C (xx) |
CO (1) | CO5251469A1 (xx) |
CZ (1) | CZ20022120A3 (xx) |
DE (2) | DE19957156A1 (xx) |
DK (1) | DK1235809T3 (xx) |
EA (1) | EA005681B1 (xx) |
EE (1) | EE200200267A (xx) |
ES (1) | ES2210036T3 (xx) |
HK (1) | HK1052176A1 (xx) |
HR (1) | HRP20020460A2 (xx) |
HU (1) | HUP0204169A3 (xx) |
IL (1) | IL149607A0 (xx) |
MX (1) | MXPA02003822A (xx) |
NO (1) | NO20022457D0 (xx) |
NZ (1) | NZ519758A (xx) |
PL (1) | PL355493A1 (xx) |
PT (1) | PT1235809E (xx) |
SK (1) | SK9302002A3 (xx) |
TR (1) | TR200302031T4 (xx) |
UA (1) | UA72566C2 (xx) |
UY (1) | UY26448A1 (xx) |
WO (1) | WO2001051471A1 (xx) |
YU (1) | YU37902A (xx) |
ZA (1) | ZA200204056B (xx) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10204276A1 (de) * | 2002-02-02 | 2003-08-07 | Boehringer Ingelheim Pharma | N-Allyloxyethyl-1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocine und ihre Verwendung als Arzneimittel |
US6683089B2 (en) | 2002-02-02 | 2004-01-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | N-allyoxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-ols |
TW201431842A (zh) * | 2012-11-09 | 2014-08-16 | Purdue Pharma Lp | 苯並嗎啡烷類似物及其應用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4121821A1 (de) * | 1991-07-02 | 1993-01-14 | Boehringer Ingelheim Kg | Neue benzomorphane und ihre verwendung als arzneimittel |
US5354758A (en) * | 1992-12-16 | 1994-10-11 | Japan Tobacco Inc. | Benzomorphans useful as NMDA receptor antagonists |
DE19740110A1 (de) * | 1997-09-12 | 1999-03-18 | Boehringer Ingelheim Pharma | Substituierte 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocin-10-ole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
DE19907874A1 (de) * | 1999-02-23 | 2000-08-24 | Boehringer Ingelheim Pharma | N-(5-Phenyl-tetrahydrofuranyl)methyl- und N-(6-Phenyl-tetrahydropyranyl)methyl substituierte 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocin-10-ole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
-
1999
- 1999-11-27 DE DE19957156A patent/DE19957156A1/de not_active Withdrawn
-
2000
- 2000-11-21 DE DE50004455T patent/DE50004455D1/de not_active Expired - Fee Related
- 2000-11-21 PT PT00993781T patent/PT1235809E/pt unknown
- 2000-11-21 UA UA2002065301A patent/UA72566C2/uk unknown
- 2000-11-21 YU YU37902A patent/YU37902A/sh unknown
- 2000-11-21 EA EA200200491A patent/EA005681B1/ru not_active IP Right Cessation
- 2000-11-21 NZ NZ519758A patent/NZ519758A/en unknown
- 2000-11-21 SK SK930-2002A patent/SK9302002A3/sk unknown
- 2000-11-21 KR KR1020027006752A patent/KR20020058042A/ko not_active Application Discontinuation
- 2000-11-21 CN CNB008162530A patent/CN1177825C/zh not_active Expired - Fee Related
- 2000-11-21 IL IL14960700A patent/IL149607A0/xx unknown
- 2000-11-21 TR TR2003/02031T patent/TR200302031T4/xx unknown
- 2000-11-21 WO PCT/EP2000/011585 patent/WO2001051471A1/de not_active Application Discontinuation
- 2000-11-21 EP EP00993781A patent/EP1235809B1/de not_active Expired - Lifetime
- 2000-11-21 CZ CZ20022120A patent/CZ20022120A3/cs unknown
- 2000-11-21 ES ES00993781T patent/ES2210036T3/es not_active Expired - Lifetime
- 2000-11-21 MX MXPA02003822A patent/MXPA02003822A/es unknown
- 2000-11-21 BR BR0015786-4A patent/BR0015786A/pt not_active Expired - Fee Related
- 2000-11-21 EE EEP200200267A patent/EE200200267A/xx unknown
- 2000-11-21 PL PL00355493A patent/PL355493A1/xx not_active Application Discontinuation
- 2000-11-21 AT AT00993781T patent/ATE254108T1/de not_active IP Right Cessation
- 2000-11-21 AU AU57897/01A patent/AU5789701A/en not_active Abandoned
- 2000-11-21 DK DK00993781T patent/DK1235809T3/da active
- 2000-11-21 HU HU0204169A patent/HUP0204169A3/hu unknown
- 2000-11-21 CA CA002383114A patent/CA2383114C/en not_active Expired - Fee Related
- 2000-11-21 JP JP2001551853A patent/JP2003519687A/ja active Pending
- 2000-11-23 AR ARP000106183A patent/AR026586A1/es not_active Suspension/Interruption
- 2000-11-24 UY UY26448A patent/UY26448A1/es not_active Application Discontinuation
- 2000-11-24 CO CO00090163A patent/CO5251469A1/es not_active Application Discontinuation
-
2002
- 2002-05-09 BG BG106682A patent/BG106682A/bg active Pending
- 2002-05-22 ZA ZA200204056A patent/ZA200204056B/en unknown
- 2002-05-24 NO NO20022457A patent/NO20022457D0/no not_active Application Discontinuation
- 2002-05-24 HR HR20020460A patent/HRP20020460A2/hr not_active Application Discontinuation
-
2003
- 2003-06-11 HK HK03104095A patent/HK1052176A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2480455C2 (ru) | 4-гидроксибензоморфаны | |
EP0679642B1 (en) | Condensed heterocyclic compounds, their production and use | |
EP0170213B1 (en) | Glutarimide antianxiety and antihypertensive agents | |
JP2002529464A (ja) | Y5受容体拮抗薬としてのスピロインドリン類 | |
JP2003528046A (ja) | フェノキシプロパノールアミン類、それらの製造および治療的使用 | |
JPS61271275A (ja) | モルヒナン誘導体 | |
CA2196769C (en) | Benzimidazole derivatives having dopaminergic activity | |
EP0558487B1 (en) | Piperidine compounds, their preparation and use | |
JP2003508528A (ja) | ヘテロアリールオキシプロパノールアミン、その製造方法及びそれらを含有する医薬組成物 | |
JP2000512644A (ja) | 5―ht―2c受容体アンタゴニストとして有用なインドリン誘導体 | |
SK9302002A3 (en) | Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3- benzazocines and the use thereof as medicaments | |
CA1236464A (en) | Indole derivatives, their preparation and pharmaceutical compositions containing them | |
US6355652B1 (en) | Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositions | |
CA1148150A (en) | Phenylmorphans, intermediates and method of preparation | |
JP5009785B2 (ja) | ウレア誘導体、それを含有する医薬組成物およびそれらの医薬用途 | |
EP1414457B1 (en) | Chiral dinapsoline | |
JP2002540108A (ja) | [S−(R*,S*)]−β−[[[1−[1−オキソ−3−(4−ピペリジニル)プロピル]−3−ピペリジニル]カルボニル]アミノ]−3−ピリジンプロパン酸及び誘導体を製造する方法 | |
EP1968970A2 (en) | Processes for the preparation of alfuzosin | |
SK14393A3 (en) | Sulfonylbenzene substituted derivatives of imidazolylpropene acid | |
US7714129B2 (en) | Methods of preparing anhydrous aripiprazole form II | |
US20070270463A1 (en) | Novel product, method and intermediates for the preparation of azetidine derivatives | |
KR810001887B1 (ko) | 페닐에틸아민류의 제조방법 | |
KR810001890B1 (ko) | 페닐에틸아민류의 제조방법 | |
PL149869B1 (pl) | Sposób wytwarzania pochodnych morfinanu |